Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Gompel

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Breast Cancer Research and Treatment|November 4, 2011
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical reviewElisabeth Luporsi, Fabrice André, Frédérique Spyratos, et al.
Presse Medicale (Paris, France : 1983)|November 13, 2018
Laurence Bouillet, Frederica Defendi, Gaelle Hardy, et al.
EMBO Molecular Medicine|September 13, 2014
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activationAnne Abot, Coralie Fontaine, Mélissa Buscato, et al.
Breast (Edinburgh, Scotland)|January 11, 2023
Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)Clara Sebbag, Christine Rousset-Jablonski, Florence Coussy, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2013
Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamideNathalie Morel, Anne Bachelot, Zeina Chakhtoura, et al.
Eclinicalmedicine|August 8, 2025
Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort studyAnne-Sophie Hamy, Agathe Chabassier, Clara Sebbag, et al.
European Journal of Cancer (Oxford, England : 1990)|June 7, 2019
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancersChristine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Bulletin Du Cancer|February 6, 2018
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 30, 2025
Contraception today and family planning: a comprehensive review and position statement on the ethical, medical, and social dimensions of modern contraceptionAndrea R Genazzani, Tiziana Fidecicchi, Domenico Arduini, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Breast Cancer Research and Treatment|November 4, 2011
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical reviewElisabeth Luporsi, Fabrice André, Frédérique Spyratos, et al.
Presse Medicale (Paris, France : 1983)|November 13, 2018
Laurence Bouillet, Frederica Defendi, Gaelle Hardy, et al.
EMBO Molecular Medicine|September 13, 2014
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activationAnne Abot, Coralie Fontaine, Mélissa Buscato, et al.
Breast (Edinburgh, Scotland)|January 11, 2023
Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)Clara Sebbag, Christine Rousset-Jablonski, Florence Coussy, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2013
Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamideNathalie Morel, Anne Bachelot, Zeina Chakhtoura, et al.
Eclinicalmedicine|August 8, 2025
Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort studyAnne-Sophie Hamy, Agathe Chabassier, Clara Sebbag, et al.
European Journal of Cancer (Oxford, England : 1990)|June 7, 2019
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancersChristine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Bulletin Du Cancer|February 6, 2018
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 30, 2025
Contraception today and family planning: a comprehensive review and position statement on the ethical, medical, and social dimensions of modern contraceptionAndrea R Genazzani, Tiziana Fidecicchi, Domenico Arduini, et al.
Pageof 13